|
Volumn 17, Issue 2, 2012, Pages 160-161
|
Maintenance of Helicobacter pylori Eradication Rates with Triple Therapy Over 12 Years in a Spanish hospital
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN;
CLARITHROMYCIN;
ESOMEPRAZOLE;
LANSOPRAZOLE;
OMEPRAZOLE;
PANTOPRAZOLE;
PROTON PUMP INHIBITOR;
RABEPRAZOLE;
UREA C 13;
ADULT;
ANTIBIOTIC RESISTANCE;
ARTICLE;
DISEASE CONTROL;
DRUG EFFICACY;
ERADICATION THERAPY;
FEMALE;
HELICOBACTER INFECTION;
HOSPITAL;
HUMAN;
INFECTION RATE;
MAJOR CLINICAL STUDY;
MALE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK REDUCTION;
SPAIN;
TREATMENT DURATION;
TREATMENT FAILURE;
UNSPECIFIED SIDE EFFECT;
UREA BREATH TEST;
AMOXICILLIN;
ANTI-BACTERIAL AGENTS;
CLARITHROMYCIN;
DRUG THERAPY, COMBINATION;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HOSPITALS;
HUMANS;
PROTON PUMP INHIBITORS;
SPAIN;
TREATMENT OUTCOME;
HELICOBACTER PYLORI;
|
EID: 84858243399
PISSN: 10834389
EISSN: 15235378
Source Type: Journal
DOI: 10.1111/j.1523-5378.2011.00922.x Document Type: Article |
Times cited : (10)
|
References (6)
|